Common drug could make top surgery recovery smoother
NCT ID NCT05794321
Summary
This study is testing if a single dose of a drug called tranexamic acid (TXA), given by IV during surgery, can reduce bleeding and fluid buildup after gender-affirming mastectomy (top surgery). Researchers will compare 150 patients who receive the drug to those who do not, measuring complications like hematoma and seroma, as well as drain output. The goal is to see if this safe, established drug can make recovery from this common surgery easier and reduce complications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE HEMATOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UCSF Department of Plastic & Reconstructive Surgery
RECRUITINGSan Francisco, California, 94131, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.